Read More

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

ADIL

Read More

Why Israel-Based Hub Cyber Security’s Stock Is Up Today

Shares of the Israel-based cyber security firm rose more than 11% on Friday and are moving on heavy volume Monday as the situation in the Middle East develops. According to data from Benzinga Pro, more than 25.8 million shares have already been traded in the session, far exceeding the stock's 100-day average volume of 3.134 million shares.

HUBC